School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, People's Republic of China.
Department of Hepatobiliary Pancreatic Oncology, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, People's Republic of China.
Int J Nanomedicine. 2023 Jul 19;18:3973-3988. doi: 10.2147/IJN.S413496. eCollection 2023.
Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass surgery, chemotherapy, radiotherapy, targeted therapy, and combination regimens. However, despite efforts to improve prognosis, and the 5-year survival rate for pancreatic cancer remains very low. Therefore, it's urgent to explore novel therapeutic approaches. With the rapid development of therapeutic strategies in recent years, new ideas have been provided for treating pancreatic cancer. This review expositions the advancements in nano drug delivery system, molecular targeted drugs, and photo-thermal treatment combined with nanotechnology for pancreatic cancer. It comprehensively analyzes the prospects of combined drug delivery strategies for treating pancreatic cancer, aiming at a deeper understanding of the existing drugs and therapeutic approaches, promoting the development of new therapeutic drugs, and attempting to enhance the therapeutic effect for patients with this disease.
胰腺癌是一种高度恶性且不可治愈的疾病,其特征为侵袭性强、致死率高。最常见的类型是胰腺导管腺癌(PDAC),其预后差,死亡率高。目前胰腺癌的治疗主要包括手术、化疗、放疗、靶向治疗和联合治疗方案。然而,尽管努力改善预后,胰腺癌的 5 年生存率仍然非常低。因此,迫切需要探索新的治疗方法。近年来,治疗策略的快速发展为胰腺癌的治疗提供了新的思路。本文综述了纳米药物传递系统、分子靶向药物以及光热治疗与纳米技术结合在胰腺癌治疗方面的研究进展,全面分析了联合药物传递策略治疗胰腺癌的前景,旨在深入了解现有药物和治疗方法,促进新型治疗药物的开发,并尝试提高患者的治疗效果。